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Abstract
Original Article
IntroductIon
Children assessed for tuberculosis (TB) are often diagnosed with 
miscellaneous pediatric disorders after extensive radiological, 
immunological, and microbiological investigations.[1] With the 
current emphasis on TB case finding, patients with alternative 
disorders are at a greater risk of being misdiagnosed with 
TB, especially in situations where diagnostic sampling is 
problematic such as in primary care, or diagnostic yield 
is suboptimal, as is often the case among children.[2,3] 
Incorrect clinical diagnosis of TB can lead to unnecessary 
antituberculous therapy (ATT) resulting in added healthcare 
costs,[4] patient morbidity from adverse effects, and suboptimal 
patient outcomes due to missed alternative diagnoses.[5] Where 
vertical programs exist, and services are not integrated, 
pediatric TB programs are not equipped to facilitate either 
the diagnosis or management of alternative disorders.[6] It 
is, therefore, necessary for pediatricians as well as national 
programs to provide referral or management for pediatric 
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disorders, especially those that commonly mimic TB.[7] 
Knowledge of such diseases is lacking among pediatricians and 
programs alike but it is important to inform policy on service 
provision and liaison with referral centers treating common 
alternative disorders.
As no previous data are available from Pakistan on childhood 
disorders mimicking TB, we evaluated a cohort of childhood 
TB suspects to establish common differentials of TB among 
children in this setting.
methods
Data source, extraction, and synthesis
All children 0–17 years of age admitted to the Aga Khan 
University Hospital (AKUH) in Karachi, Pakistan and 
evaluated for TB through culture or Xpert MTB/RIF® 
(Cepheid, Sunnyvale, USA) results from January 2014 
to December 2015 were included in the study. AKUH is 
a tertiary care center located in the most populous city of 
Pakistan and provides advanced diagnostic and treatment 
services to a large catchment population, many of whom are 
referred from other public and private centers. The hospital, 
therefore, serves as a reference center for some communicable 
and noncommunicable illnesses; however, referrals are not 
coordinated through vertical disease control programs. The 
hospital and its affiliated laboratory are accredited by the Joint 
Commission International (JCI), USA and follow JCI patient 
safety and healthcare quality goals and guidelines.
To determine the most common alternative disorders among 
children evaluated for TB, a relational laboratory database 
was created to identify children for whom mycobacterial 
cultures or Xpert MTB/RIF® results were negative for all 
evaluated samples. The project commenced in June 2016. 
Medical records were examined for ICD‑9 coded hospital 
diagnoses (diagnoses alternative to TB or clinical diagnosis 
of TB despite negative cultures), comorbidities, and age, 
for both pulmonary and extrapulmonary presentations. The 
database was then refined to include children with pulmonary 
and extrapulmonary syndromic presentations, to increase 
specificity by excluding children who were investigated as 
TB contacts. For pulmonary presentations, children with 
chronic cough, hemoptysis, recurrent pneumonia, pneumonia 
in HIV infected children, and loculated pleural effusions were 
included. For extrapulmonary presentations, children with 
lymphadenopathy, chronic abdominal symptoms, pericarditis, 
central nervous system (CNS) disorders indicated by fever, 
headache and/or seizures, pyrexia of unknown origin (PUO), 
and chronic skin and soft tissue and bone and joint infections 
were included. Data collected included patients’ age, sex, 
diagnoses, and the use of ATT in primary care before facility 
presentation where available, hospital diagnosis at the study 
facility, and surgical and medical care administered at the 
facility. The follow‑up to date, and where possible, disease 
outcomes were documented (long‑term follow‑up care, death, 
loss to follow up, transfers, and palliative care).
Data analysis
Data entry and analysis were carried out with IBM SPSS 
Statistics version 19.0 (IBM Corp, New York, USA). 
Frequencies, medians, and interquartile ranges were calculated 
using the same software.
Ethics
The study protocol was reviewed and approved by the Ethical 
Review Committee for the Aga Khan University (approval 
number 4168‑Pat‑ERC‑16) and was exempted from individual 
informed consent.
results
Description of the cohort
The initial laboratory database identified 270 pediatric patients 
from January 2014 to December 2015 evaluated for TB but 
with negative microbiology results. Database refinement by 
presentation resulted in the exclusion of 137 patients. Of 
126 patients with negative culture or Xpert results, 38.1% 
(n = 48) were evaluated for pulmonary TB (pulmonary 
presentations), whereas 61.9% (n = 78) were investigated 
for disseminated or extrapulmonary disease (extrapulmonary 
presentations). The median age of the cohort was 8 years 
(IQR 8.25). The male‑to‑female ratio was 1.6 overall and for 
both pulmonary and extrapulmonary presentations.
Table 1 shows the distribution of the final cohort across 
pulmonary and extrapulmonary presentations and diagnoses.
Alternative diagnoses for pulmonary presentations
Although multiple alternative pulmonary disorders were 
observed in the cohort [Table 1], a high proportion of 
underlying bronchiectasis was detected. Of the 9 patients with 
bronchiectasis, none had a past history of being treated for 
asthma, TB, pertussis, and/or measles, and were presumptively 
diagnosed with “cystic fibrosis” (CF) on the basis of clinical 
symptom complex representing chronic and recurrent 
pneumonia, excessive sputum production, weight loss, and 
incremental loss of pulmonary function, despite normal sweat 
chloride levels and unavailable CF transmembrane regulator 
gene mutation testing.[8] Bacterial pneumonia with loculated 
empyema (n = 25) was the most frequently identified alternative 
infection, with most children with prior histories of inadequate 
treatment of community‑acquired pneumonia. Of note, these 
children improved on antibiotics, chest intubation, and 
video‑assisted thoracoscopic surgery (VATS) for debridement 
of the pleural space. Five patients were diagnosed with TB on 
the basis of clinical criteria (Kenneth Jones) and treated for TB, 
one of whom was empirically treated for multidrug‑resistant 
TB but was lost to follow‑up after 2 months.
Alternative diagnoses for extrapulmonary presentations
Among extrapulmonary presentations, TB remained the 
most common diagnosis despite negative microbiological 
investigations (n = 26, 33.3%). Lymphoproliferative 
disorders (lymphomas, leukemias, and hemophagocytic 
lymphohistiocytosis‑[HLH]) (n = 11, 21.1%), and bacterial 
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Contd...
Table 1: Alternative final diagnoses and patient outcomes among children with negative tests tuberculosis, January 
2014‑December 2015
Presenting 
syndrome/
indication for 
TB testing
Patients 
(n)
Median 
age 
years 
(IQR)
Samples tested Final diagnoses (n) Patient outcomes 
(n)
Empiric ATT use 
during course of 
illness, n/N (%)*
Pulmonary 
presentations
48 7 (7) Followed up (38), 
LTFU (7), expired (3)
9/43 (20.9)
Chronic cough 20 Gastric aspirate (12)
Sputum/tracheal 
aspirate (7), pus 
from abscess (1)
Bronchiectasis (4), TB (3), necrotizing 
pneumonia (2), lung abscess (2), 
H. influenzae pneumonia (1), 
pneumococcal pneumonia (1), M. 
kansasii pneumonia (1), aspiration 
pneumonia (1), reactive airway disease 
(1), CGD (1), fungal pneumonia (1), 
CCAM (1), neuroendocrine tumor (1)
Loculated 
pleural effusion/
empyema
15 Pleural tissue (15) 
obtained after VATS
Empyema requiring thoracotomy and 
VATS: TB (1), presumed bacterial 
empyema (10), pneumococcal empyema 
(2), S. typhimurium infection with SCID 
(1), P. aeruginosa empyema (1)
Recurrent 
pneumonia
7 Sputum (3), 
bronchial (1), 
gastric aspirate (2), 
lung tissue (1)
Underlying bronchiectasis (5), 
ventricular septal defect with bacterial 
pneumonia (1), foreign body aspiration 
(1)
Pneumonia in 
HIV
4 Gastric aspirate (3), 
pleural fluid (1)
Bacterial pneumonia (3)
Hemoptysis 2 Sputum (2) Bacterial pneumonia (1); pulmonary 
TB, suspected MDR (1)
Extrapulmonary 
presentations
78 9 (8) Followed up (60), 
LTFU (13), expired 
(3), sent home on 
palliative care (1), 
transferred to MDR 
TB facility (1)
16/52 (30.8)
Abdominal 
symptoms
13
Ascites 2 Primary Budd‑Chiari (1), TB (1)
Diarrhea 1 Crohn’s disease (1)
Perforation/
obstruction
3 Abdominal tuberculosis (3)
Chronic pain/
distension
7 Abdominal tuberculosis (5), Burkitt’s 
lymphoma (1), appendiceal abscess (1)
Acute respiratory 
distress and 
pericarditis
4 MICE (1), idiopathic (1), Pompe’s 
disease (1), Campylobacter pericarditis 
in HIV (1)
CNS 23
Space 
occupying 
lesion
8 Bacterial abscess (3), fungal abscess (1), 
tuberculoma (1), tumor (3)
Meningitis‑ 
encephalitis
10 TBM (7), subdural haemorrhage (1), 
multisystem cerebral leukoclastic 
angiitis (1), acute cerebellitis (1)
Lower limb 
paresis
5 Transverse myelitis (2), Ewing’s 
sarcoma (2), ADEM (1)
PUO 30 TB (8), lymphoma (7), leukemia 
(2), enteric fever (2), M. kansasii 
disseminated infection (1), JRA 
(2), HLH (1), AIHA (1), CVID (2), 
CGD (1), neuroendocrine tumor (1), 
Neimann‑Pick disease (1), intestinal 
amebiasis (1)
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infections (enteric fever, bacterial brain abscess, appendiceal 
abscess, Staphylococcus aureus infections, Mycobacterium 
kansasii disseminated disease, and Campylobacter pericarditis 
in an HIV‑infected patient) (n = 11; 21.1%) were the 
most frequent mimickers of TB among extrapulmonary 
presentations, followed by autoimmune disorders (Crohn’s 
disease, transverse myelitis, juvenile rheumatoid arthritis‑JRA, 
autoimmune hemolytic anemia, leukoclastic angiitis, acute 
cerebellitis, and acute disseminated encephalomyelitis) (n = 9, 
17.3%). Primary immunodeficiencies were identified in 9.6% 
of patients (n = 5; chronic granulomatous disease‑[CGD], 
common variable immunodeficiency [CVID], and severe 
combined immunodeficiency).
Primary and secondary care tuberculosis diagnosis 
among children with alternative disorders
Of 95 children in whom TB was ruled out and alternative 
diagnoses were established, 25.8% (n = 25) were diagnosed with 
and treated for TB for the same presenting complaints (similar 
episode of illness) before being evaluated at the study facility 
(9 of 43, 20.9% in the pulmonary group, and 16 of 52, 30.8% in 
the extrapulmonary group). Bronchiectasis was the most frequent 
pulmonary condition among children misdiagnosed as having 
TB in the primary healthcare setting (n = 5), others being CGD, 
Pseudomonas aeruginosa empyema, M. kansasii pneumonia, 
and pulmonary neuroendocrine tumor. Lymphoproliferative 
disorders were most frequently misdiagnosed as TB among 
extrapulmonary presentations (n = 8), where 4, patients with 
Hodgkin’s lymphoma, and 1 patient each with T‑cell acute 
lymphoblastic leukemia, diffuse large b cell lymphoma, Burkitt’s 
lymphoma, and HLH, respectively, received ATT but failed 
to improve. Other disorders where patients were prescribed 
ATT without subsequent improvement included Ewing’s 
sarcoma (n = 2), transverse myelitis (n = 1), S. milleri brain 
abscess (n = 1), CVID (n = 1), intestinal amebiasis (n = 1), 
JRA (n = 1), and malabsorption syndrome (n = 1).
Patient outcomes
Six patients died during the hospital course (n = 6, 4.8%, one 
each with pneumococcal pneumonia, necrotizing P. aeruginosa 
pneumonia, bronchiectasis, HLH, Hodgkin’s lymphoma, and 
disseminated TB). A large proportion of patients were lost to 
follow‑up (n = 20, 15.9%).
dIscussIon
Although differentials for TB are legion,[9] they help in drawing 
attention to common diagnostic pitfalls. Our analysis shows 
that pediatric disorders mimicking TB and treated with ATT 
include nonTB bronchiectasis and CF, unresolved bacterial 
pneumonia ± empyema without underlying bronchiectasis, 
lymphoproliferative disorders, autoimmune disorders, and 
primary immunodeficiencies.
Cystic fibrosis is a previously under‑recognized differential 
of pediatric pulmonary TB, and an underdiagnosed entity in 
Pakistan due to limitations of diagnostic tests available.[10] 
This presents a serious challenge given the lack of reference 
centers for diagnosis or for multidisciplinary management 
for CF in Pakistan.[11] Survival of CF patients is negatively 
impacted by the limited availability of pediatric pulmonology 
services, thoracic imaging, bronchoscopy, pulmonary function 
testing, and lung transplantation facilities to support diagnosis 
and care.[12] Such services need to be established to facilitate 
management of CF in Pakistan.
Another major differential of TB was unresolved bacterial 
pneumonia and loculated empyema. This is likely due to 
inadequate treatment of childhood bacterial pneumonia in 
primary care, leading to either residual or recurrent infection, 
sepsis, and loculated effusions requiring surgical management. 
As with the care of CF, availability of centers with facilities for 
advanced pulmonary care and VATS is necessary for optimal 
management of such patients.[13]
Pediatric lymphoproliferative disorders emerged as a principal 
differential for extrapulmonary presentations such as PUO, 
where such patients received empiric ATT. This reflects the 
inadequate identification of these disorders in primary care, 
a concern which has been highlighted before by Mushtaq 
et al.[14] A high index of suspicion is required to diagnose and 
Table 1: Contd...
Presenting 
syndrome/
indication for 
TB testing
Patients 
(n)
Median 
age 
years 
(IQR)
Samples tested Final diagnoses (n) Patient outcomes 
(n)
Empiric ATT use 
during course of 
illness, n/N (%)*
Other 
(lymphadenitis, 
septic arthritis, 
chronic weight 
loss)
8 Paradoxical response to ATT (2), 
S. aureus infections (3), TB (1), 
malabsorption syndrome (1), unresolved 
(1)
Total 126 8 (8.25) 25/95 (26.3)
*Those clinically diagnosed with TB excluded. CGD: Chronic granulomatous disease, CCAM: Congenital cystic adenomatoid malformation, CNS: Central 
nervous system, PUO: Pyrexia of unknown origin, TBM: Tuberculous meningitis, SCID: Severe combined immune deficiency, MICE: Mesothelial/monocytic 
incidental cardiac excrescence, JRA: Juvenile rheumatoid arthritis, HLH: Hemophagocytic lymphohistiocytosis, AIHA: Autoimmune hemolytic anemia, 
CVID: Common variable immune deficiency, TB: Tuberculosis, IQR: Interquartile range, ATT: Antituberculous therapy, LTFU: Lost to follow‑up, VATS: 
Video assisted thoracoscopic surgery, MDR: Multidrug resistant, ADEM: Acute disseminated encephalomyelitis, H. influenza: Haemophilus influenza, M. 
kansasii: Mycobacterium kansasii, S. typhimurium: Salmonella typhimurium, P. aeruginosa: Pseudomonas aeruginosa, S. aureus: Staphylococcus aureus
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manage hematological malignancies early to reduce resulting 
morbidity and mortality.
Tuberculosis remained a frequent diagnosis in children 
with negative microbiological tests for Mycobacterium 
tuberculosis, especially for extrapulmonary (PUO, CNS and 
abdominal) presentations. Based on the inherent difficulty of 
diagnosing extrapulmonary TB among children, this result 
was expected.[15] Microbiological tests available for TB at the 
time were subpar[16,17] owing to low analytical sensitivities; 
however, detection rates are expected to improve with wider 
implementation and use of Xpert Ultra for extrapulmonary TB.
Our results highlight the need to implement changes in the 
health system at three levels. First, equipping HCPs at the 
primary and secondary level to build a practical differential 
and investigate as per resource locally, when children present 
with pulmonary and extrapulmonary illnesses which may 
mimic TB. Second, for cases that remain unresolved at the 
primary and secondary level referral to tertiary care/advanced 
pediatric care facility through a recognized facilitated referral 
loop established by the Local Health Ministry to confirm 
diagnoses and manage common childhood disorders such as 
bacterial pneumonia and childhood malignancies. Third, we 
have highlighted the need to develop, validate, and implement 
algorithms for the diagnosis and management of difficult 
clinical entities such as autoimmune disorders and CF at 
all levels of health care. As a first step, at the primary and 
secondary care level, physicians have to be educated and case 
files regularly audited to assess patient outcomes. There is also 
an imminent need to establish reference centers specializing 
in the management of children who are excluded from the TB 
register. To prevent loss to follow‑up and to ensure continuity 
of clinical care, referrals to these centers need to be organized 
actively or facilitated.
In modestly organized health systems with vertical programs, 
the facilitated referral has been shown to work effectively in 
optimal management of medical conditions.[18] Facilitated 
referral in childhood infectious disorders is expected to 
reduce morbidity and mortality while monitoring referral 
practices.[19] Since adequate diagnosis and management of 
several alternative disorders identified here require modalities, 
expertise, and equipment that may only be available in 
tertiary care settings[20,21] facilitated referral is superior to 
passive referral which usually results in high levels of loss to 
follow up. In resource limited settings, facilitated referral is 
likely the best option to manage disorders mimicking TB. It 
is therefore important to identify common differentials and 
relative occurrence of TB in each setting to advise referral 
service linkages.[22] An example is the child lung health 
program in Malawi which was modeled on the prevalence and 
epidemiology of childhood diseases.[23] Rasmussen et al.[24] 
advocated strengthening measures in developing countries 
to facilitate optimal management in healthcare settings. For 
optimal management of pediatric patients, TB program clinics 
in Pakistan serving pediatric populations should be linked with 
centers for diagnosis and facilitated management of chronic 
childhood pneumonia, bronchiectasis, CF, and pediatric 
malignancies.
Our results, while instrumental in understanding the need 
for facilitated referral, have limitations. First, we derived a 
laboratory‑centric database and not a syndromic database as 
the primary data source due to its ready availability. However, 
purposive refinement of this database allowed us to determine 
alternative diagnoses by clinical features at presentation. Second, 
data from one hospital may not be generalizable to the entire 
country’s population. Diagnostic skills of pediatricians (index 
of suspicion, clinical judgment, knowledge, and experience with 
alternative presentations such as CF) involved may also have 
impacted our results due to inherent difficulties in diagnosing 
childhood TB. Heterogeneity due to variations in clinical 
practice means that incidence figures cannot be derived as 
proportions are not a true depiction of the population.
conclusIons
This study highlights the importance of continuing care and 
surveillance for children who are ineligible for enrollment in 
TB registers but continue to need high‑level medical care. 
Children who test negative for TB should be referred to tertiary 
care centers to improve their health outcomes by identification 
and management of some alternative disorders which have high 
morbidity and mortality. Facilitated referral strategies are a 
time‑honored solution to optimize resources while addressing 
such challenges.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
references
1. Rojpibulstit M, Kanjanakiritamrong J, Chongsuvivatwong V. Patient 
and health system delays in the diagnosis of tuberculosis in Southern 
Thailand after health care reform. Int J Tuberc Lung Dis 2006;10:422‑8.
2. Yunda LF, Sepúlveda EV, Herrera KC, Moreno GC. Pulmonary 
tuberculosis in a pediatric reference hospital in Bogotá, Colombia. Int J 
Mycobacteriol 2017;6:258‑63.
3. Djouahra AM, Ifticene M, Boulahbal F. The difficulties of childhood 
tuberculosis diagnosis. Biomed Biotechnol Res J 2017;1:55‑8.
4. Laurence YV, Griffiths UK, Vassall A. Costs to health services and 
the patient of treating tuberculosis: A systematic literature review. 
Pharmacoeconomics 2015;33:939‑55.
5. Houben RM, Lalli M, Kranzer K, Menzies NA, Schumacher SG, 
Dowdy DW, et al. What if they don’t have tuberculosis? The 
consequences and trade‑offs involved in false‑positive diagnoses of 
tuberculosis. Clin Infect Dis 2019;68:150‑6.
6. Bjerrum S, Rose MV, Bygbjerg IC, Mfinanga SG, Tersboel BP, Ravn P, 
et al. Primary health care staff’s perceptions of childhood tuberculosis: 
A qualitative study from Tanzania. BMC Health Serv Res 2012;12:6.
7. World Health Organization. Dept. of Child, Adolescent Health. 
Management of the Child with a Serious Infection or severe malnutrition: 
Guidelines for Care at the First‑Referral Level in Developing Countries. 
World Health Organization; 2000.
8. Boyle MP. Nonclassic cystic fibrosis and CFTR‑related diseases. Curr 
Opin Pulm Med 2003;9:498‑503.
[Downloaded free from http://www.ijmyco.org on Sunday, April 12, 2020, IP: 39.44.64.224]
Shakoor, et al.: Alternative diagnoses to tuberculosis in children
International Journal of Mycobacteriology ¦ Volume 8 ¦ Issue 1 ¦ January‑March 2019 47
9. Gie RP, Beyers N, Schaaf HS, Nel ED, Smuts NA, van Zyl S, et al. TB 
or not TB? An evaluation of children with an incorrect initial diagnosis 
of pulmonary tuberculosis. S Afr Med J 1995;85:658‑62.
10. Bhutta ZA, Moattar T, Shah U. Genetic analysis of cystic fibrosis in 
Pakistan: A preliminary report. J Pak Med Assoc 2000;50:217‑9.
11. Bowler IM, Estlin EJ, Littlewood JM. Cystic fibrosis in Asians. Arch 
Dis Child 1993;68:120‑2.
12. Mirtajani SB, Farnia P, Hassanzad M, Ghanavi J, Farnia P, Velayati AA. 
Geographical distribution of cystic fibrosis; The past 70 years of data 
analysis. Biomed Biotechnol Res J 2017;1:105.
13. Wait MA, Beckles DL, Paul M, Hotze M, Dimaio MJ. Thoracoscopic 
management of empyema thoracis. J Minim Access Surg 2007;3:141‑8.
14. Mushtaq N, Fadoo Z, Naqvi A. Childhood acute lymphoblastic 
leukaemia: Experience from a single tertiary care facility of Pakistan. 
J Pak Med Assoc 2013;63:1399‑404.
15. Held M, Bruins MF, Castelein S, Laubscher M, Dunn R, Hoppe S, 
et al. A neglected infection in literature: Childhood musculoskeletal 
tuberculosis – A bibliometric analysis of the most influential papers. Int 
J Mycobacteriol 2017;6:229‑38.
16. Bajrami R, Mulliqi G, Kurti A, Lila G, Raka L. Assessment of diagnostic 
accuracy of genexpert Mycobacterium tuberculosis/rifampicin in 
diagnosis of pulmonary tuberculosis in Kosovo. Biomed Biotechnol Res 
J 2018;2:191‑5.
17. Jeanes C, O’Grady J. Diagnosing tuberculosis in the 21st century – Dawn 
of a genomics revolution? Int J Mycobacteriol 2016;5:384‑91.
18. Baumgartner JN, Green M, Weaver MA, Mpangile G, Kohi TW, 
Mujaya SN, et al. Integrating family planning services into HIV care 
and treatment clinics in Tanzania: Evaluation of a facilitated referral 
model. Health Policy Plan 2014;29:570‑9.
19. Winch PJ, Gilroy KE, Wolfheim C, Starbuck ES, Young MW, 
Walker LD, et al. Intervention models for the management of children 
with signs of pneumonia or malaria by community health workers. 
Health Policy Plan 2005;20:199‑212.
20. Theart AC, Marais BJ, Gie RP, Hesseling AC, Beyers N. Criteria used 
for the diagnosis of childhood tuberculosis at primary health care level 
in a high‑burden, urban setting. Int J Tuberc Lung Dis 2005;9:1210‑4.
21. Ramos JM, Tesfamariam A, Balcha S, Biru D, Reyes F, 
Górgolas M, et al. Management and transference of patients diagnosed 
with tuberculosis in a rural hospital in Southern Ethiopia. Int J 
Mycobacteriol 2013;2:79‑83.
22. Graham SM, Gie RP, Schaaf HS, Coulter JB, Espinal MA, Beyers N, 
et al. Childhood tuberculosis: Clinical research needs. Int J Tuberc Lung 
Dis 2004;8:648‑57.
23. Enarson PM, Gie R, Enarson DA, Mwansambo C. Development 
and implementation of a national programme for the management of 
severe and very severe pneumonia in children in Malawi. PLoS Med 
2009;6:e1000137.
24. Rasmussen Z, Pio A, Enarson P. Case management of childhood 
pneumonia in developing countries: Recent relevant research and 
current initiatives. Int J Tuberc Lung Dis 2000;4:807‑26.
[Downloaded free from http://www.ijmyco.org on Sunday, April 12, 2020, IP: 39.44.64.224]
